Ll. Von Moltke et al., Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects, BIOL PSYCHI, 46(6), 1999, pp. 839-849
Background: Biotransformation of citalopram (CT), a newly available selecti
ve serotonin reuptake inhibitor antidepressant, to its principal metabolite
, desmethycitalopram (DCT), and the capacity of CT and DCT to inhibit human
cytochromes P450, were studied in vitro.
Methods: Formation of DCT from CT was evaluated using human liver microsome
s and microsomes from cDNA-transfected human lymphoblastoid cells. Cytochro
me inhibition by CT and DCT in liver microsomes was studied using isoform-s
pecific index reactions.
Results: Formation of DCT from CT in liver microsomes had a mean apparent K
-m of 174 mu mol/L. Coincubation with I mu mol/L ketoconazole reduced react
ion velocity to 46 to 58% of control values, while omeprazole, 10 mu mol/L,
reduced velocity to 80% of control. Quinidine produced minimal inhibition.
DCT was formed from CT by heterologously expressed human P450-2D6, -2C19,
-3A4. After accounting for the relative abundance of individual cytochromes
, 3A4 and 2C19 were estimated to make major contributions to net reaction v
elocity, with a possible contribution of 2D6 at therapeutic CT concentratio
ns. CT and DCT themselves produced negligible inhibition of 2C9, 2E1, and 3
A, and only weak inhibition of 1A2 2C19, and 2D6
Conclusions: Formation of DCT from CT is mediated mainly by P450-3A4 and 2C
19, with an additional contribution of 2D6 CT at therapeutic doses in human
s may produce a small degree of inhibition of P450-1A2, -2C19, and -2D6 but
negligible inhibition of P450-2C9, -2E1, and -3A. (C) 1999 Society of Biol
ogical Psychiatry.